Non-invasive screening for the most commmon chromosomal aneuploidies as early as 10 weeks gestation, using a single maternal blood drawOrder Test Kit
NIPT, also known as cell-free DNA (cfDNA) screening, is a cutting edge aneuploidy screening option. NIPT safely and noninvasively screens for the most common chromosomal aneuploidies as early as 10 weeks gestation, using a single maternal blood draw.
It detects abnormalities in chromosomes such as
Microdeletions are chromosomal disorders caused by small missing pieces of chromosome material. Some occur more commonly in a specific area of a particular chromosome and have been linked to known genetic syndromes. Most occur by chance, rather than by being inherited from a parent, and can occur with no prior family history and without other risk factors.
The capabilities of NIPT have been expanded to help detect 5 specifcing microdeletion regions. By doing so, the NIPT microdeletion panel can provide valuable information to aid in pregnancy management and prepartion for newborn care.